Although this study was not powered to detect treatment-related changes in clinical PTSD symptoms, assignment to the L. Reuteri arm was associated with a decrease in plasma CRP levels that approached statistical significance, suggesting that CRP may be a useful biomarker to monitor treatment effect in future studies. This evidence concerns the gene CRP and post-traumatic stress disorder.